about
New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.Effect of Copper Acyclovir Complexes on Herpes Simplex Virus Type 1 and Type 2 (HSV-1, HSV-2) Infection in Cultured Cells.Interactions of metal ions with DNA, its constituents and derivatives, which may be relevant for anticancer research.Characterization of ciprofloxacin binding to the linear single- and double-stranded DNA.Synthesis, characterization and crystal structures of two pentagonal-bipyramidal Fe(III) complexes with dihydrazone of 2,6-diacetylpyridine and Girard's T reagent. Anticancer properties of various metal complexes of the same ligand.Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates.Synthesis, characterization, DFT calculation and biological activity of square-planar Ni(II) complexes with tridentate PNO ligands and monodentate pseudohalides. Part II.Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo.Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity.New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium.Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.Synthesis, characterization, cytotoxic activity and DNA binding properties of the novel dinuclear cobalt(III) complex with the condensation product of 2-acetylpyridine and malonic acid dihydrazide.Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine.Combined therapy of the antimetastatic compound NAMI-A and electroporation on B16F1 tumour cells in vitro.In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds.First ruthenium organometallic complex of antibacterial agent ofloxacin. Crystal structure and interactions with DNA.Di-μ-chlorido-bis-{chlorido[(R)/(S)-1,5-di-phenyl-3-(2-pyridyl-κN)-2-pyrazoline-κN]zinc(II)}.New method for the speciation of ruthenium-based chemotherapeutics in human serum by conjoint liquid chromatography on affinity and anion-exchange monolithic disks.NMR Investigation of the Copper(II)-Ciprofloxacin System.Ruthenium complexes as inhibitors of the aldo-keto reductases AKR1C1-1C3.Physicochemical Studies and Anticancer Potency of Ruthenium η-p-Cymene Complexes Containing Antibacterial QuinolonesNickel-quinolones interaction. Part 5-Biological evaluation of nickel(II) complexes with first-, second- and third-generation quinolones.Intermolecular C-H...pi interactions in 1,5-diphenyl-3-(2-pyridyl)-2-pyrazoline.Click-triazole N2 coordination to transition-metal ions is assisted by a pendant pyridine substituent.Nickel-quinolones interaction: part 3--Nickel(II) complexes of the antibacterial drug flumequine.Nickel-quinolones interaction. Part 2--interaction of nickel(II) with the antibacterial drug oxolinic acid.Crystal structure of ciprofloxacin hydrochloride 1.34-hydrate.Interactions of oxovanadium(IV) and the quinolone family member--ciprofloxacin.Influence of copper(II) and magnesium(II) ions on the ciprofloxacin binding to DNA.A novel copper(II) complex with 1,10-phenanthroline and ciprofloxacin.Solution, solid state and biological characterization of ruthenium(III)-DMSO complexes with purine base derivatives.Mixed-valence Cu(II)/Cu(I) complex of quinolone ciprofloxacin isolated by a hydrothermal reaction in the presence of L-histidine: comparison of biological activities of various copper-ciprofloxacin compounds.Antioxidant capacity and DNA-interaction studies of zinc complexes with a non-steroidal anti-inflammatory drug, mefenamic acid.Special issue: practical applications of metal complexes.Non-steroidal anti-inflammatory drug diflunisal interacting with Cu(II). Structure and biological features.Experimental electron density study of a complex between copper(II) and the antibacterial quinolone family member ciprofloxacin.First- and second-generation quinolone antibacterial drugs interacting with zinc(II): structure and biological perspectives.Synthesis, characterization and DNA binding of magnesium-ciprofloxacin (cfH) complex [Mg(cf)2] * 2.5H2O.Antibacterial tests of bismuth(III)-quinolone (ciprofloxacin, cf) compounds against Helicobacter pylori and some other bacteria. Crystal structure of (cfH2)2[Bi2Cl10].4H2O.
P50
Q30828082-85FB5F1F-8EFD-4B6B-99D1-078F7F900311Q33862825-88BE45E2-B06C-4E59-80FC-584B96C259A4Q36626564-3387151D-DD7F-4AE5-B682-87BD516B02D5Q37951063-1E5A98A8-8DD6-4BD4-B528-FE7E56A54D2AQ38352023-EE1C87F9-DEDA-4C06-BF65-3523B3FA4B52Q38698239-5836847B-2148-4AF8-8727-B19F91E68499Q38889354-0AF877F1-343E-490A-A5BF-D107121BFCAEQ38952738-25748CBF-017C-44B7-BEA5-C74628D417EBQ38981930-4DA04991-3574-4CB7-A4CD-23322419E9A3Q39000218-4228F1A5-BAB7-4C9F-8ED9-BE3829248A2CQ39120504-B6626CB9-7C25-4EE7-93BF-AF1E3236C61FQ39295123-6F5C0C3F-09AD-4C07-9F0E-1B5B10893E11Q39514489-A2235B4A-3A7C-4133-8B61-2C0C8FA32823Q39856936-41EE66A8-1EE1-4309-BD61-5C26AB095A5BQ40113266-E609C667-A72C-436A-9533-C10A7121ECDAQ40739397-406C951F-6563-43A6-937E-1D6D083FB2FCQ41367590-136C159A-A264-43FA-9790-EDAE4988FD91Q41372727-A22C0288-1B8F-41A8-85DC-4D7AD2C93CFBQ41747028-F03615E7-4591-4108-BA90-38CCBB145E12Q41785075-295DDB2A-6D46-4FA4-BA7D-F9BAF0356DB8Q42703449-44668633-B644-42BA-94E2-24BEE9EB7C00Q42725980-7932EF84-D56A-4871-8834-4339370CAA63Q42728156-A982A315-D341-4FCC-8B00-691AB6457635Q43044896-C68A8E2B-DB59-4B7F-96CA-F611F95DDC37Q43074852-ADFF63D6-C591-4F8D-A08B-19567B5FD9CBQ43093321-EFB394AE-09E0-4541-A4E9-25F7EF841850Q43235525-8F89B602-FAE6-46E9-B1A5-EF64780D1F59Q44331147-DDEF9496-591D-4998-9B91-FD011984EB20Q44451659-8A6CE9DC-05A4-4217-BC31-BC197A7EBE4CQ44530744-E3A370EA-1FD3-48E2-A876-073DD4D46264Q44566146-C1611B91-B2D8-4909-B939-2D5082B92FF0Q44732519-6A84707E-262E-4BD8-8ED4-D384E0844B4DQ45203545-3BF7EE87-C210-41E1-B8B2-784799634F72Q45344637-755C6BD9-B56E-49D2-A7BE-B2D1F0C06395Q48264159-41A1CD08-9BD8-4961-A073-38637EF54097Q51501598-9C3BB4B5-5308-4333-8926-2B99D451365AQ51914224-FEA9F464-8C36-4875-BFBA-82A0F182194DQ53122805-C2D6B933-E334-47A8-8206-69984109A8F9Q53526854-76F7EF42-6F69-4003-8AF2-F536D964852FQ53802409-1F849C20-A3EA-44FE-8B40-FF14A6785304
P50
description
Sloveenia keemik
@et
Slovene chemist
@en
ceimiceoir Slóivéanach
@ga
chimist sloven
@ro
chimiste slovène
@fr
kimist slloven
@sq
químic eslovè
@ca
químico esloveno
@es
químico esloveno
@gl
scheikundige uit Slovenië
@nl
name
Iztok Turel
@ast
Iztok Turel
@en
Iztok Turel
@es
Iztok Turel
@fr
Iztok Turel
@ga
Iztok Turel
@nl
Iztok Turel
@sl
Iztok Turel
@sq
type
label
Iztok Turel
@ast
Iztok Turel
@en
Iztok Turel
@es
Iztok Turel
@fr
Iztok Turel
@ga
Iztok Turel
@nl
Iztok Turel
@sl
Iztok Turel
@sq
prefLabel
Iztok Turel
@ast
Iztok Turel
@en
Iztok Turel
@es
Iztok Turel
@fr
Iztok Turel
@ga
Iztok Turel
@nl
Iztok Turel
@sl
Iztok Turel
@sq
P214
P1053
A-1516-2008
P1153
7003316141
P1280
P19
P21
P214
P31
P3829
P496
0000-0001-6776-4062
P569
1964-04-15T00:00:00Z
P6556
P735
P7859
viaf-305537644